Glycopyrrolate Injection
Product Images NDC 76045-023

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 76045-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Gly0c 0000 01)

Illustration displaying the components of a Glycopyrrolate injection syringe, including the outer package, plunger rod, syringe barrel, label (marked 'Do not remove'), luer lock collar (marked 'Do not remove'), and syringe tip cap.*

FDA Label Image

Figure 2 (Gly0c 0000 02)

An instructional line drawing showing two hands opening a sealed blister pack to remove a prefilled syringe, likely illustrating the preparation step for administering a medication injection.*

FDA Label Image

Figure 3 (Gly0c 0000 03)

An instructional illustration showing a pair of hands unscrewing the cap from a small vial or container. The image demonstrates how to open the container, likely for administering Glycopyrrolate injection.*

FDA Label Image

Structural Formula (Gly0c 0000 04)

Chemical structure of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight of 398.33. The structure includes a bromide ion and distinct functional groups consistent with glycopyrrolate's chemical identity.*

FDA Label Image

Fresenius Kabi Logo (Gly0c 0000 05)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Syringe Label)

Label for Glycopyrrolate Injection, USP in a 3 mL single-dose prefilled syringe. The strength shown is 0.6 mg per 3 mL (0.2 mg/mL). It is indicated for intramuscular or intravenous use and is Rx only. The label includes a barcode, lot number placeholder, expiration date placeholder, and the manufacturer Fresenius Kabi.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Glycopyrrolate Injection, USP, 0.6 mg/3 mL (0.2 mg/mL) injection solution. The label indicates usage for intramuscular or intravenous administration. It includes directions for storage at 20° to 25°C and specifies that the solution is preservative-free and presented as a 3 mL single-dose prefilled syringe from Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate Injection, USP 3 mL Carton Label)

Glycopyrrolate Injection, USP 0.6 mg/3 mL (0.2 mg/mL) single-dose prefilled syringes carton label for intramuscular or intravenous use. The preservative-free product is labeled for 10 x 3 mL syringes and manufactured by Fresenius Kabi USA, LLC. The label includes storage instructions, barcode, and usage precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.